Global Retirement Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Global Retirement Partners’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.44K	Buy	+158	New	+$3.29K	﹤0.01%	3819
2025 Q4	$5.64K	Buy	269 +111	+70%	+$1.94K	﹤0.01%	3397
2025 Q3	$2.42K	Sell	158 -157	-50%	-$2.06K	﹤0.01%	3252
2025 Q2	$2.95K	Buy	+315	New	+$3.47K	﹤0.01%	3094
2024 Q4	$5.22K	Buy	395 +80	+25%	+$1.37K	﹤0.01%	2661
2024 Q3	$6.06K	Hold	315	–	–	﹤0.01%	2481
2024 Q2	$6.47K	Hold	315	–	–	﹤0.01%	2492
2024 Q1	$7.5K	Hold	315	–	–	﹤0.01%	2240
2023 Q4	$7.04K	Sell	315 -6	-2%	-$92	﹤0.01%	2197
2023 Q3	$3.9K	Buy	321 +6	+2%	+$113	﹤0.01%	2276
2023 Q2	$6.59K	Hold	315	–	–	﹤0.01%	2107
2023 Q1	$6.42K	Hold	315	–	–	﹤0.01%	2084
2022 Q4	$8.02K	Hold	315	–	–	﹤0.01%	1862
2022 Q3	$7K	Sell	315 -166	-35%	-$3.72K	﹤0.01%	1828
2022 Q2	$9K	Hold	481	–	–	﹤0.01%	1696
2022 Q1	$7K	Buy	+481	New	+$8.1K	﹤0.01%	1790
2021 Q4	–	Sell	-315	Closed	-$6K	–	1549
2021 Q3	$6K	Buy	+315	New	+$5.25K	﹤0.01%	1575

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Global Retirement Partners's SNDX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 158 shares worth $3.44K. The stake represents ﹤0.01% of the portfolio and ranks #3819 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in SNDX as recently as Q4 2025.

Global Retirement Partners first reported a position in SNDX in Q3 2021 and has held it in 17 quarters since. The position peaked at $9K in Q2 2022. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Global Retirement Partners held 158 shares of Syndax Pharmaceuticals worth $3.44K as of Q2 2026.
Syndax Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
Syndax Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3819 holding.
Global Retirement Partners first reported a position in Syndax Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
Global Retirement Partners's Syndax Pharmaceuticals position peaked at $9K in Q2 2022.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.